<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04098939</url>
  </required_header>
  <id_info>
    <org_study_id>Diaphragm Study AUH</org_study_id>
    <nct_id>NCT04098939</nct_id>
  </id_info>
  <brief_title>Evaluation of Diaphragm Movement</brief_title>
  <official_title>Vurdering af Diafragmas Funktion. Et Metodestudie og et Klinisk Studie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Precise measurement of diaphragm function is difficult. Several methods exist. No are
      sufficiently validated.

      With this study, the investigators wish to investigate the validity of different ultrasound
      and radiological methods and compare them with inspiratory pressure measurements.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragm function</measure>
    <time_frame>immediately after intervention</time_frame>
    <description>Movement of diaphragm measured with ultrasound and radiography. Ultrasound measures: Diaphragm excursion in centimeters with M-mode, in B-mode and with the area method.
Radiographic measures: Craio-caudal movement in centimeters with flouroscopy.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diaphragm Disease</condition>
  <arm_group>
    <arm_group_label>Healthy participants</arm_group_label>
    <description>Participants without any known cardiac or pulmonary disease.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heart disease participants</arm_group_label>
    <description>Participants with heart disease.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lung disease participants</arm_group_label>
    <description>Participants with lung disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diaphragm evaluation</intervention_name>
    <description>Ultrasound and radiographic evaluation of diaphragm function</description>
    <arm_group_label>Healthy participants</arm_group_label>
    <arm_group_label>Heart disease participants</arm_group_label>
    <arm_group_label>Lung disease participants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: Healthy participants. Group 2: Lung disease. Group 3: Heart disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Completed informed consent

          -  one of the following conditions:

               -  Healthy participants, control group

               -  Lung disease group.

                    -  COPD or

                    -  Ideopatic pulmonary fibrosis.

               -  Heart disease group.

        Heart disease that lead to:

          -  heart transplantat or

          -  left ventricular assist device.

        Exclusion Criteria:

          -  Known diaphragm dysfunction.

          -  Neuromuscular disease.

          -  Pleural effusion.

          -  Pneumothorax.

          -  In the healthy group: Significant comorbidity that affect heart og lung function
             (arterial hypertention, mild valve disease and COPD without symptoms are accepted).

          -  In the healthy group and in the lung disease group: Previous thorax surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Søren H Skaarup</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Juhl-Olsen</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian Løgstrup</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Birkelund</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morten Bendixen</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Søren H Skaarup</last_name>
    <phone>28911869</phone>
    <email>soeska@rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Søren Helbo Skaarup</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Søren H Skaarup</last_name>
      <phone>28911869</phone>
      <email>soeska@rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

